FBRX - Forte Biosciences GAAP EPS of -$0.32 May, 15 2023 05:04 PM Forte Biosciences Inc. 2023-05-15 17:04:01 ET Forte Biosciences press release ( NASDAQ: FBRX ): Q1 GAAP EPS of -$0.32. Forte ended the first quarter 2023 with approximately $35.9 million in cash and cash equivalents. For further details see: Forte Biosciences GAAP EPS of -$0.32